Suprachoroidal Delivery of Anti-Angiogenic Peptide Microparticles Enables Sustained Activity with Favorable Ocular Safety
Adam C. Mirando, Raquel Lima e Silva, Jikui Shen…·Niranjan B. Pandey
This study evaluates suprachoroidal delivery of AXT107 microparticles for treating retinal and choroidal vascular diseases, showing reduced neovascularization and favorable safety.